Description

Dibenz(B,E)(1,4)Oxazepine-11-Ethanamine, 5,11-Dihydro-5-Ethyl-N,n-Dime Thyl-, (+-)-, (E)-2-Butenedioate (1:1) is a specialized organic compound of significant interest in advanced chemical synthesis. This material serves as a critical intermediate or active pharmaceutical ingredient (API) for research and development in medicinal chemistry. It is primarily sought by pharmaceutical R&D laboratories, fine chemical manufacturers, and academic institutions engaged in the development of novel therapeutic agents.

Application

• Pharmaceutical Intermediate: Key building block in the synthesis of novel active pharmaceutical ingredients (APIs) targeting central nervous system (CNS) disorders.
• Medicinal Chemistry Research: Used in lead optimization and structure-activity relationship (SAR) studies for drug discovery programs.
• Fine Chemical Synthesis: Serves as a precursor for the production of complex, high-value specialty chemicals.
• Biochemical Research: Potential tool compound for investigating specific biochemical pathways and receptor interactions in vitro.
• Contract Manufacturing: Supplied to CDMOs (Contract Development and Manufacturing Organizations) for custom synthesis projects under cGMP conditions.

Basic Information

Product Name	Dibenz(B,E)(1,4)Oxazepine-11-Ethanamine, 5,11-Dihydro-5-Ethyl-N,n-Dime Thyl-, (+-)-, (E)-2-Butenedioate (1:1)
CAS No.	86640-32-6
Molecular Formula	C23H28N2O5
Molecular Weight	412.48 g/mol
Synonyms	5-Ethyl-11-(N,N-dimethylaminoethyl)dibenz[b,e][1,4]oxazepine fumarate; CR 339 fumarate; Dibenzoxazepine fumarate salt; 11-(2-Dimethylaminoethyl)-5-ethyldibenz[b,e][1,4]oxazepine fumarate; (±)-5-Ethyl-11-(2-(dimethylamino)ethyl)dibenz[b,f][1,4]oxazepine fumarate (1:1); (E)-Butenedioic acid compound with 5-ethyl-11-[2-(dimethylamino)ethyl]dibenz[b,e][1,4]oxazepine (1:1); CR-339 fumarate
EINECS	Contact for details

Quality Control

Our Dibenz(B,E)(1,4)Oxazepine-11-Ethanamine, 5,11-Dihydro-5-Ethyl-N,n-Dime Thyl-, (+-)-, (E)-2-Butenedioate (1:1) is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the stringent requirements for pharmaceutical research applications. Certificates of Analysis (COA) detailing all specifications and test results are provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed after each use to prevent degradation from atmospheric moisture.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 1.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.